Acting CEO Litha Pharma Division: Selwyn Kahanovitz Litha Pharma aims to provide a broad offering of medicines from complimentary to ethical and generic prescription medicines. Through the acquisition in 2010 of Pharmafrica, an existing and successful local company, Litha Pharma established a presence in the field of Cardiovascular medicine, Dermatology, Urology, Ophthalmology and other disciplines.

However, the overall business focus within Litha Pharma is to develop more presence in retail pharmacy as well as expand access to healthcare professionals who prescribe ethical, OTC and generic medicines.

In early 2011 Litha announced the signing of a new business development agreement with CPoint Inc, a Canadian based company. This partnership will assist Litha Pharma in accessing international pipelines. During 2011 CPoint Inc. facilitated the signing of supplier agreements with Micro Labs Limited (India), Gland Pharma Limited (India), Natco Pharma (India) and NTC s.r.l (Italy) .

Litha Pharma made two other acqusitions in 2011, Goldex Healthcare and OTC Pharma SA. Goldex Healthcare manufactures and distributes medicines under license from Unichem laboratories with a focus on the generic medicine market. This will expand Litha Pharma's presence in pharmacy and to dispensing doctors. OTC Pharma SA has a group of well-established international brands and will see Litha Pharma expanding its existing natural healthcare porfolio. 

The following business units operate within Litha Pharma:

• Prescribing porfolio: Pharmafrica (Pty) Ltd
• Retail Pharmacy portfolio: Goldex Healthcare and OTC Pharma SA (Pty) Ltd

Litha Pharma is based in Johannesburg, South Africa and distributes products throughout South Africa through various distribution networks.